ALGORAE PHARMACEUTICALS LIMITED — Director's Dealing 2010

Jan 3, 2010

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.

Name of entity LIVING CELL TECHNOLOGIES LTD ABN 104 028 042

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	MR DAVID L BROOKES
Date of last notice	25 NOVEMBER 2009

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	DIRECT
Nature of indirect interest(including registered holder)Note: Provide details of the circumstances giving rise to the relevantinterest.
Date of change	29 DECEMBER 2009

• See chapter 19 for defined terms.

Appendix 3Y Page 1

11/3/2002

Appendix 3Y Change of Director’s Interest Notice

No. of securities held prior to change	100,000 ORDINARY SHARES	(HELD BY
	DAVID LIONEL BROOKES)
	335,000 ORDINARY SHARES (HELD BY
	DR DAVID LIONEL BROOKES &	MRS
	ELISABETH BROOKES <DR DL	BROOKES
	PERSONAL SUPERFUND A/C>)
	50,000 ORDINARY SHARES	(HELD BY
	MRSELISABETHMARY	BROOKES
	<DAHLBROOK FAMILY A/C>)
	150,000 OPTIONS – EXERCISABLE AT
	$0.20 EACH, VESTING 28/08/2008 AND
	EXPIRING 30/11/2012
	250,000 OPTIONS – EXERCISABLE AT
	$0.30 EACH, VESTING 28/08/2008 AND
	EXPIRING 30/11/2012
	250,000 OPTIONS (HELD BY MRS
	ELISABETH MARY BROOKES
	<DAHLBROOK FAMILY A/C>) –
	EXERCISABLE AT $0.25 EACH,	VESTING
	23/8/2010 AND EXPIRING 19/11/2014
	250,000 OPTIONS (HELD BY MRS
	ELISABETH MARY BROOKES
	<DAHLBROOK FAMILY A/C>) –
	EXERCISABLE AT $0.35 EACH,	VESTING
	23/8/2010 AND EXPIRING 19/11/2014
Class	ORDINARY SHARES
Number acquired	60,000
Number disposed	NIL
Value/Consideration	$0.25 PER SHARE
Note: If consideration is non-cash, provide details and estimated
valuation

• See chapter 19 for defined terms.

Appendix 3Y Page 2

11/3/2002

Appendix 3Y Change of Director’s Interest Notice

	No. of securities held after change	No. of securities held after change	No. of securities held after change	100,000 ORDINARY SHARES (HELD BYDAVID LIONEL BROOKES)395000 ORDINARY SHARES HELD BY	100,000 ORDINARY SHARES (HELD BYDAVID LIONEL BROOKES)395000 ORDINARY SHARES HELD BY
				, (DR DAVID LIONEL BROOKES & MRS
				ELISABETH BROPERSONAL SUPE	KES <DR DL BROOKESRFUND A/C>)
				50000 ORDINARY SHARES (HELD BY
				,MRSELISABETDAHLBROOK F	HMARYBROOKESMILY A/C
				<	>)
				150,000 OPTION$0.20 EACH, VE	S – EXERCISABLE ATSTING 28/08/2008 AND
				EXPIRING 30/11/2	012
				250,000 OPTION030 EACH V	S – EXERCISABLE ATSTING 28/08/2008 AND
				$. ,EXPIRING 30/11/2	012
				250,000 OPTIONS	(HELD BY MRS
				ELISABETH MARY BROOKES<DAHLBROOK FAMILY A/C>) –EXERCISABLE AT $0.25 EACH, VESTING23/8/2010 AND EXPIRING 19/11/2014250,000 OPTIONS (HELD BY MRSELISABETH MARY BROOKES<DAHLBROOK FAMILY A/C>) –EXERCISABLE AT $0.35 EACH, VESTING23/8/2010 AND EXPIRING 19/11/2014
	Nature of changeExample: on-market trade, off-market trade, exercise of options, issue ofsecurities under dividend reinvestment plan, participation in buy-back			PARTICIPATION IN SHARE PURCHASEPLAN

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

	Detail of contract	Detail of contract	Detail of contract	N/A	N/A	N/A	N/A
	Nature of interest
	Name of registered holder(if issued securities)
	Date of change
	No. and class of securi		ties to which
	interest related prior toNote: Details are only required for ato which the interest has changed		changecontract in relation
	It	t id
	ner	s acqure

• See chapter 19 for defined terms.

Appendix 3Y Page 3

11/3/2002

Appendix 3Y Change of Director’s Interest Notice

Interest disposed Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation Interest after change

• See chapter 19 for defined terms.

Appendix 3Y Page 4

11/3/2002